Assignee
IPSEN PHARMA SAS
FR·49 granted patents·47 pending applications·321 citations·filing 2003–2025
Top patents by PatentIndex Score
96 records- 0194US8039435B2Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2006·Granted Oct 18, 2011·15 cites·2 claims
- 0293US8377865B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2008·Granted Feb 19, 2013·13 cites·12 claims
- 0392US7858789B2Derivatives of 4-aminopiperidine and their use as a medicamentIPSEN PHARMA SAS·Filed 2008·Granted Dec 28, 2010·16 cites·1 claims
- 0491US8034808B2Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabineIPSEN PHARMA SAS·Filed 2005·Granted Oct 11, 2011·128 cites·20 claims
- 0589US7576241B2Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing themIPSEN PHARMA SAS·Filed 2005·Granted Aug 18, 2009·12 cites·6 claims
- 0688US9850280B2Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2017·Granted Dec 26, 2017·3 cites·9 claims
- 0788US8349797B2Ligands of melanocortin receptorsIPSEN PHARMA SAS·Filed 2006·Granted Jan 8, 2013·11 cites·43 claims
- 0888US7932231B2Compositions and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2006·Granted Apr 26, 2011·10 cites·25 claims
- 0988US7816539B2Derivatives of benzimidazole and imidazo-pyridine and their use as medicamentsIPSEN PHARMA SAS·Filed 2009·Granted Oct 19, 2010·11 cites·6 claims
- 1085US8859729B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2013·Granted Oct 14, 2014·4 cites·9 claims
- 1185US2026085092A1Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2025·Application pending·0 cites
- 1284US10206968B2Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogsIPSEN PHARMA SAS·Filed 2016·Granted Feb 19, 2019·2 cites·17 claims
- 1384US7517853B2Somatostatin-dopamine chimeric analogsIPSEN PHARMA SAS·Filed 2004·Granted Apr 14, 2009·19 cites·2 claims
- 1483US8952128B2Somatostatin-dopamine chimeric analogsIPSEN PHARMA SAS·Filed 2013·Granted Feb 10, 2015·5 cites·8 claims
- 1583US2024182519A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2023·Application pending·0 cites
- 1681US9409948B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2014·Granted Aug 9, 2016·2 cites·7 claims
- 1781US8017637B2Inhibitors of cdc phosphatasesIPSEN PHARMA SAS·Filed 2005·Granted Sep 13, 2011·9 cites·24 claims
- 1881US7795284B24,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic usesIPSEN PHARMA SAS·Filed 2005·Granted Sep 14, 2010·9 cites·12 claims
- 1981US7662784B2Method for decreasing body weight using a somatostatin receptor agonistIPSEN PHARMA SAS·Filed 2005·Granted Feb 16, 2010·2 cites·10 claims
- 2081US2022127305A1Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2022·Application pending·0 cites
- 2179US7763725B2Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptorsIPSEN PHARMA SAS·Filed 2005·Granted Jul 27, 2010·4 cites·21 claims
- 2278US7956075B2Derivatives of heterocycles with 5 members, their preparation and their use as medicamentsIPSEN PHARMA SAS·Filed 2007·Granted Jun 7, 2011·3 cites·18 claims
- 2378US2022339239A1Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2022·Application pending·0 cites
- 2477US9096609B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2012·Granted Aug 4, 2015·5 cites·10 claims
- 2576US9370520B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2015·Granted Jun 21, 2016·3 cites·9 claims
- 2676US7977455B2Analogues of GLP-1IPSEN PHARMA SAS·Filed 2007·Granted Jul 12, 2011·1 cites·14 claims
- 2776US7897566B2Analogues of GLP-1IPSEN PHARMA SAS·Filed 2004·Granted Mar 1, 2011·8 cites·2 claims
- 2876US7638546B1Imidazolyl derivativesIPSEN PHARMA SAS·Filed 2007·Granted Dec 29, 2009·2 cites·4 claims
- 2976US2020347110A1Composition and Methods for Stimulating Gastrointestinal MotilityIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 3075US7589058B2Ghrelin analogsIPSEN PHARMA SAS·Filed 2003·Granted Sep 15, 2009·8 cites·16 claims
- 3174US9827286B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2016·Granted Nov 28, 2017·1 cites·10 claims
- 3273US2021163536A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2021·Application pending·0 cites
- 3372US9499599B2Composition and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2015·Granted Nov 22, 2016·1 cites·24 claims
- 3472US9439943B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2015·Granted Sep 13, 2016·1 cites·17 claims
- 3572US9296783B2Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2013·Granted Mar 29, 2016·1 cites·26 claims
- 3672US2020095281A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 3772US2009270341A1Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancerIPSEN PHARMA SAS·Filed 2009·Application pending·0 cites
- 3871US7999061B2Catalytic lactide and glycolide (co)polymerization systemIPSEN PHARMA SAS·Filed 2008·Granted Aug 16, 2011·2 cites·15 claims
- 3971US7790680B2Stable pharmaceutical composition containing factor VIIIIPSEN PHARMA SAS·Filed 2003·Granted Sep 7, 2010·5 cites·7 claims
- 4070US2020017548A1Growth Hormone Releasing PeptidesIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 4169US2018305406A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 4267US10543249B2Pharmaceutical composition for a sustained release of lanreotideIPSEN PHARMA SAS·Filed 2014·Granted Jan 28, 2020·1 cites·7 claims
- 4367US2018105557A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 4467US2020360483A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2020·Application pending·0 cites
- 4565US10787696B2System for the assessment of protease activityIPSEN PHARMA SAS·Filed 2013·Granted Sep 29, 2020·0 cites·11 claims
- 4665US7754253B2Botulinum toxin for the treatment of reduction of hair growthIPSEN PHARMA SAS·Filed 2005·Granted Jul 13, 2010·4 cites·18 claims
- 4765US2019062374A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 4865US2017362275A1Growth Hormone Releasing PeptidesIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 4964US2019167754A1Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogsIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 5064US2016368962A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when IPSEN PHARMA SAS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →